WCA
PRVB

Windsor Creek Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Windsor Creek Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,000
Closed -$305K – 216
2020
Q4 		$305K Sell
18,000
-10,492
-37% -$157K 0.08% 149
2020
Q3 		$366K Buy
28,492
+18,300
+180% +$231K 0.1% 130
2020
Q2 		$144K Sell
10,192
-3,808
-27% -$48.1K 0.05% 152
2020
Q1 		$129K Buy
+14,000
New +$180K 0.05% 152

Other funds holding PRVB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Windsor Creek Advisors's PRVB Position: Q1 2021 in Review

Windsor Creek Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q1 2021, closing a stake of 18,000 shares — an estimated $305K sold.

Windsor Creek Advisors first reported a position in PRVB in Q1 2020 and held it in 4 quarters. The position peaked at $366K in Q3 2020. 120 funds tracked by Wall St. Rank hold PRVB as of Q1 2021.

  • Windsor Creek Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Windsor Creek Advisors sold 18,000 Provention Bio, Inc. Common Stock shares in Q1 2021, an estimated $305K.
  • Windsor Creek Advisors first reported a position in Provention Bio, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Windsor Creek Advisors's Provention Bio, Inc. Common Stock position peaked at $366K in Q3 2020.
  • 120 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2021.

Based on Windsor Creek Advisors's 13F filing for Q1 2021, filed 13 May 2021.